No products in the cart.

Anti-USP13 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-07-2219
Anti-USP13 antibody
Erpan Tech In stock

Specifications        

Product Cat#: AB-07-2219
Product type: Primary antibody
Antigen: USP13
Immunogen: The antiserum was produced against synthesized peptide derived from internal of human USP13.
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:500-1:2500); ELISA (1:35000)
Reactivity: Human, Mouse
Clonality (clone number): Polyclonal
Form: Liquid
Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration: 1 mg/ml
Purity: Antigen affinity chromatography
Storage: Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles.
Alternative names: Ubiquitin carboxyl-terminal hydrolase 13; EC 3.1.2.15; Ubiquitin thioesterase 13; Ubiquitin-specific-processing protease 13; Deubiquitinating enzyme 13; Isopeptidase T-3; ISOT-3; USP13; ISOT3
Show More

Target information

Deubiquitinase that mediates deubiquitination of target proteins such as BECN1, MITF, SKP2 and USP10 and is involved in various processes such as autophagy and endoplasmic reticulum-associated degradation (ERAD). Component of a regulatory loop that controls autophagy and p53/TP53 levels: mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34-containing complexes. Also deubiquitinates USP10, an essential regulator of p53/TP53 stability. In turn, PIK3C3/VPS34-containing complexes regulate USP13 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Recruited by nuclear UFD1 and mediates deubiquitination of SKP2, thereby regulating endoplasmic reticulum-associated degradation (ERAD). Also regulates ERAD through the deubiquitination of UBL4A a component of the BAG6/BAT3 complex. Mediates stabilization of SIAH2 independently of deubiquitinase activity: binds ubiquitinated SIAH2 and acts by impairing SIAH2 autoubiquitination. Has a weak deubiquitinase activity in vitro and preferentially cleaves ‘Lys-63’-linked polyubiquitin chains. In contrast to USP5, it is not able to mediate unanchored polyubiquitin disassembly. Able to cleave ISG15 in vitro; however, additional experiments are required to confirm such data.

Provider

Erpantech Laboratory

download

MSDS-AB-07-2219.pdf (168 downloads )